Contrast agents are compounds routinely used in clinical analysis to enhance differentiation between tissues or to increase the visibility of structures or fluids within the body, thus facilitating medical diagnosis. A study led by researcher Lucia Cardo and Ikerbasque research professor and AXA chair Maurizio Prato (both at CIC biomaGUNE) confirms that manganese-doped carbon nanodots could be the next generation of contrast agents for magnetic resonance imaging.
Manganese-doped carbon nanodots could rival existing MRI contrast agents
Leave a Comment